Eli Lilly treatment for Alzheimer's disease gets 'breakthrough therapy designation' from FDA
INDIANAPOLIS -- The U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation for Eli Lilly's investigational antibody therapy for Alzheimer's disease. The F…
